Sanj K Patel Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

KNSA Quotes by TradingView

Sanj K Patel is CHAIRMAN & CEO of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 79,551 shares of KNSA, which is worth approximately $1.73 Million. The most recent transaction as insider was on Mar 21, 2022, when has been sold 18,555 shares (Class A Common Share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.6K
26.25% 3M change
51.48% 12M change
Total Value Held $1.73 Million

Sanj K Patel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 21 2022
BUY
Exercise of conversion of derivative security
-
18,555 Added 44.44%
23,202 Class A Common Share
Mar 16 2022
SELL
Payment of exercise price or tax liability
$19,470 $10.13 p/Share
1,922 Reduced 29.26%
4,647 Class A Common Share
Mar 16 2022
BUY
Exercise of conversion of derivative security
-
6,569 Added 50.0%
6,569 Class A Common Share
Feb 10 2021
SELL
Open market or private sale
$36,896 $23.06 p/Share
1,600 Reduced 100.0%
0 Class A Common Shares
Feb 10 2021
BUY
Exercise of conversion of derivative security
$2,544 $1.59 p/Share
1,600 Added 50.0%
1,600 Class A Common Shares
Feb 09 2021
SELL
Open market or private sale
$470,039 $23.04 p/Share
20,401 Reduced 100.0%
0 Class A Common Shares
Feb 09 2021
BUY
Exercise of conversion of derivative security
$32,438 $1.59 p/Share
20,401 Added 50.0%
20,401 Class A Common Shares
Feb 08 2021
SELL
Open market or private sale
$113,252 $23.0 p/Share
4,924 Reduced 100.0%
0 Class A Common Shares
Feb 08 2021
BUY
Exercise of conversion of derivative security
$7,829 $1.59 p/Share
4,924 Added 50.0%
4,924 Class A Common Shares
Oct 12 2020
SELL
Open market or private sale
$3,167,714 $21.02 p/Share
150,700 Reduced 100.0%
0 Class A Common Shares
Oct 12 2020
BUY
Exercise of conversion of derivative security
$239,613 $1.59 p/Share
150,700 Added 50.0%
150,700 Class A Common Shares
Oct 09 2020
SELL
Open market or private sale
$18,312 $21.0 p/Share
872 Reduced 100.0%
0 Class A Common Shares
Oct 09 2020
BUY
Exercise of conversion of derivative security
$1,386 $1.59 p/Share
872 Added 50.0%
872 Class A Common Shares
SKP

Sanj K Patel

CHAIRMAN & CEO
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KNSA